Responsiveness of observer rating scales by analysis of number of days until improvement in patients with major depression
Authors:
- N LaugeNLN Lauge
- K BehnkeKBK Behnke
- J SøgaardJSJ Søgaard
- B BahrBBB Bahr
- P BechPBP Bech
- 1 May 1998
- journal article
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 13 (3) , 143-145
Abstract
Summary: Several well-known observer scales, including the Hamilton Depression Scale (HAM-D), Montgomery-Åsberg Scale (MADRS), Major Depression Rating Scale (MDS), Melancholia Scale (MES), and Inventory for Depressive Symptomatology (IDS) used for measuring severity of depressive states have been compared by their responsiveness in an open trial including patients treated with a combination of citalopram and mianserin. The patients fulfilled the Diagnostic and Statistical Manual (DSM)-IV criteria for major depressive episode, and all scored 18 or more on the HAM-D before treatment. Onset of antidepressant action was defined as an improvement of rating scale scores of 25% or more of pre-treatment scores. A response to treatment was defined as a reduction of 50% or more on the pre-treatment scores. The results showed that the number of treatment days until improvement was 11 to 13 with no difference between the scales. The days until response were between 18 and 21 with no difference between the scales. In conclusion, the depression scales were found to be equal in their ability to detect changes in depressive symptoms during treatment. The mean of days to response was 19 for the combination of citalopram and mianserin. This is similar to the response for the combination of fluoxetine and pinolol.Keywords
This publication has 11 references indexed in Scilit:
- Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatmentThe Lancet, 1997
- Onset of action under antidepressant treatmentEuropean Psychiatry, 1997
- The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trialsJournal of Affective Disorders, 1997
- Severity at baseline and onset of improvement in depression. Meta-analysis of imipramine and moclobemide versus placeboEuropean Psychiatry, 1994
- Time course of improvement under antidepressant treatment: A survival-analytical approachEuropean Neuropsychopharmacology, 1993
- Combined Treatment with Imipramine and MianserinPharmacopsychiatry, 1992
- The inventory for depressive symptomatology (IDS): Preliminary findingsPsychiatry Research, 1986
- Identification of True Drug Response to AntidepressantsArchives of General Psychiatry, 1984
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- Two Dosages of Imipramine in Hospitalized Endogenous and Neurotic DepressivesArchives of General Psychiatry, 1976